US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust NYSE Arca Biotechnology Index Fund

265.02

+2.030.77%

Post-market: 265.020.00000.00%19:30 EDT

Volume:42.25K

Turnover:11.21M

Market Cap:2.88B

PE:31.01

High:266.64

Open:263.60

Low:263.60

Close:262.99

52wk High:274.99

52wk Low:173.98

Shares:10.85M

Float Shares:10.85M

Volume Ratio:1.48

T/O Rate:0.39%

Dividend:- -

Dividend Rate:- -

EPS(TTM):8.55

EPS(LYR):37.75

ROE:19.96%

ROA:-0.16%

PB:1.03

PE(LYR):7.02

Loading ...

Overview Company News Filings

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

Milton Essex boosts Sanford Biotech capital to drive advanced mastitis cell therapy

Mizuho survey shows no consensus into Alkermes ADHD data

Bruker Announces BRL 0.02 Dividend Per Unit for Q3 2026

Bruker BEST, Luvata Enter Strategic Collaboration to Supply RRP Superconductors for Fusion Magnets

Best and Luvata Announce Collaboration Agreement for Supply of High-Performance Rrp® Superconductors for Magnetic Confinement Fusion

THOMSON REUTERS

Corcept Names Roberto Vieira as President, Oncology in Initial Beneficial Ownership Filing

Alkermes EVP, CLO David Joseph Gaffin Disposes of 2,034 Common Shares Worth $97,651.34

Veracyte Director Muna Bhanji Disposes of 1,864 Common Shares Worth $80,086.08

uniQure seeks accelerated approval for Huntington’s gene therapy

Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874

Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

Circio boosts circVec gene therapy data and secures funding runway to 2030

Corcept Therapeutics Insider Makes Major Multimillion-Dollar Stock Move

Labcorp to Present at Morgan Stanley Healthcare Conference

Corcept Endocrinology President Sean Maduck Disposes of 30,955 Corcept Shares Worth $3.88 Million

Analysts Have Conflicting Sentiments on These Healthcare Companies: NeoGenomics (NEO) and Medtronic (MDT)

NeoGenomics RaDaR ST Gains Expanded Medicare Coverage for Immunotherapy Response Monitoring

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/FBT/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","market":"US","secType":"STK","nameCN":"First Trust NYSE Arca Biotechnology Index Fund","latestPrice":265.02,"timestamp":1789588800000,"preClose":262.99,"halted":0,"volume":42247,"hourTrading":{"tag":"盘后","latestPrice":265.02,"preClose":265.02,"latestTime":"19:30 EDT","volume":17,"amount":4505.34,"timestamp":1789601405208,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.007718924673941871,"floatShares":10850002,"shares":10850002,"eps":8.545272,"marketStatus":"Not Yet Opened","change":2.03,"latestTime":"09-16 16:00:00 EDT","open":263.6,"high":266.64,"low":263.6,"amount":11212835.415800001,"amplitude":0.011559,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":8.545272,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":262.99,"sharesOutstanding":11450002,"nav":263.09,"aum":2867681526.18,"bidAskSpread":0.001046,"postHourTrading":{"tag":"盘后","latestPrice":265.02,"preClose":265.02,"latestTime":"19:30 EDT","volume":17,"amount":4505.34,"timestamp":1789601405208,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.479744,"impliedVol":0.1995,"impliedVolPercentile":0.3426},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","floatShares":10850002,"roa":"-0.16%","roe":"19.96%","lyrEps":37.754725,"volumeRatio":1.479744,"shares":10850002,"dividePrice":0,"high":266.64,"amplitude":0.011559,"preClose":262.99,"low":263.6,"week52Low":173.975,"pbRate":"1.03","psRate":"693.68","week52High":274.99,"institutionHeld":0,"latestPrice":265.02,"eps":8.545272,"divideRate":0,"volume":42247,"delay":0,"ttmEps":8.545272,"open":263.6,"prevYearClose":206.52,"prevWeekClose":261.85,"prevMonthClose":267.15,"prevQuarterClose":247.89,"fiveDayClose":265.563,"twentyDayClose":260.7392,"sixtyDayClose":229.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBT\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FBT","amount":1.1726,"announcedDate":"2024-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust NYSE Arca Biotechnology Index Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"market":"US","date":"2022-01-10","symbol":"FBT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1641790800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-12-30","symbol":"FBT","amount":2.2136,"defaultRemindTime":1640874600000,"name":"First Trust NYSE Arca Biotechnology Index Fund","recordDate":"2022-01-10","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBT\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-10","value":2.2136,"currency":"USD"},{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":1.1726,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBT\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APXH","GNMX","MDTX","MNTL","PINK","RSPH","MRNY","TBXU","BBH","GSKH","PSCH","SURI","MEDX","IBBQ","IDNA","BIB","PBE","HYLG","FHLC","GNOM","JHMH","LFSC","SBIO","SYNB","XPH","GPCR","CNCR","FBT","PTH","LENZ","WDNA","BBP","MEDI","IBRN","PJP","PSIL","BME","GDOC","IBBJ","JDOC","CURE","HRTS","FTXH","FXH","LLYX","NVIB","AZNH","CANC","PBPH","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665101723","title":"Milton Essex boosts Sanford Biotech capital to drive advanced mastitis cell therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2665101723","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665101723?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:47","pubTimestamp":1788806848,"startTime":"0","endTime":"0","summary":"MILTON ESSEX S.A. ( ($PL:MTN) ) just unveiled an announcement. Milton Essex S.A., acting as sole shareholder of Sanford Biotech, has approved a PLN...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/milton-essex-boosts-sanford-biotech-capital-to-drive-advanced-mastitis-cell-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/milton-essex-boosts-sanford-biotech-capital-to-drive-advanced-mastitis-cell-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTNmain","GNOM","BK4588","LFSC","BK4585","FBT","BK4581","SYNB","XBI","IBB","TBXU","IBBQ","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665735956","title":"Mizuho survey shows no consensus into Alkermes ADHD data","url":"https://stock-news.laohu8.com/highlight/detail?id=2665735956","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665735956?lang=en_us&edition=fundamental","pubTime":"2026-09-05 03:35","pubTimestamp":1788550508,"startTime":"0","endTime":"0","summary":"Mizuho conducted a survey of 13 investors ahead of Alkermes (ALKS)’ Phase 1b trial of ALKS-7290 in adult attention-deficit/hyperactivity disorder, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mizuho-survey-shows-no-consensus-into-alkermes-adhd-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mizuho-survey-shows-no-consensus-into-alkermes-adhd-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","FBT","IBRN","PSCH","ADHD","MEDX","ALKS","ABVC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665356339","title":"Bruker Announces BRL 0.02 Dividend Per Unit for Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665356339","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665356339?lang=en_us&edition=fundamental","pubTime":"2026-09-05 02:15","pubTimestamp":1788545720,"startTime":"0","endTime":"0","summary":"Bruker announces BRL 0.02 dividend per unit for Q3 2026Bruker declared a Q3 2026 cash dividend of R$ 0.02 per unit for BRB2RKBDR 003.Shares trade with entitlement through Sept. 17.Payment is scheduled for Oct. 14.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief on September 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL8CZ3L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TINY","LU1815336091.USD","BRKR","FBT","LU0757428866.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664338151","title":"Bruker BEST, Luvata Enter Strategic Collaboration to Supply RRP Superconductors for Fusion Magnets","url":"https://stock-news.laohu8.com/highlight/detail?id=2664338151","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664338151?lang=en_us&edition=fundamental","pubTime":"2026-09-04 14:01","pubTimestamp":1788501692,"startTime":"0","endTime":"0","summary":"Bruker BEST, Luvata enter strategic collaboration to supply RRP superconductors for fusion magnetsBruker’s BEST unit formed a strategic collaboration with Luvata Materials & Solutions to scale supply ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL7z0b9f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TINY","BK4121","LU0757428866.USD","BRKR","LU1815336091.USD","BRUKP","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381329","title":"Best and Luvata Announce Collaboration Agreement for Supply of High-Performance Rrp® Superconductors for Magnetic Confinement Fusion","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381329","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381329?lang=en_us&edition=fundamental","pubTime":"2026-09-04 14:00","pubTimestamp":1788501600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nTUA2TXNVY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TINY","LU1815336091.USD","LU0757428866.USD","BRKR","FBT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664800115","title":"Corcept Names Roberto Vieira as President, Oncology in Initial Beneficial Ownership Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664800115","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664800115?lang=en_us&edition=fundamental","pubTime":"2026-09-04 08:40","pubTimestamp":1788482411,"startTime":"0","endTime":"0","summary":"Corcept names Roberto Vieira as President, Oncology in initial beneficial ownership filingCorcept Therapeutics President, Oncology Roberto Wandenkolk Vieira disclosed 4,068 common shares in an initial","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL3ZgV8J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","BK4007","LU1559883803.SGD","LU0566484027.USD","FBT","CORT","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664802637","title":"Alkermes EVP, CLO David Joseph Gaffin Disposes of 2,034 Common Shares Worth $97,651.34","url":"https://stock-news.laohu8.com/highlight/detail?id=2664802637","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664802637?lang=en_us&edition=fundamental","pubTime":"2026-09-04 06:33","pubTimestamp":1788474793,"startTime":"0","endTime":"0","summary":"Alkermes EVP, CLO David Joseph Gaffin disposes of 2,034 common shares worth $97,651.34Alkermes EVP and chief legal officer David Joseph Gaffin sold 2,034 ordinary shares on Sep. 3, 2026 at USD 48.01.D","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL5DSLJB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP, CLO David Joseph Gaffin Disposes of 2,034 Common Shares Worth $97,651.34","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","BK4139","IBRN","ALKS","PSIL","PSCH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664043388","title":"Veracyte Director Muna Bhanji Disposes of 1,864 Common Shares Worth $80,086.08","url":"https://stock-news.laohu8.com/highlight/detail?id=2664043388","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664043388?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:49","pubTimestamp":1788468557,"startTime":"0","endTime":"0","summary":"Veracyte director Muna Bhanji disposes of 1,864 common shares worth $80,086.08Veracyte director Muna Bhanji sold 1,864 shares of common stock on Sep. 1, 2026 at $42.97.Direct holdings fell to 42,718 s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL4tYL9N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Veracyte Director Muna Bhanji Disposes of 1,864 Common Shares Worth $80,086.08","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VCYT","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819175","title":"uniQure seeks accelerated approval for Huntington’s gene therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819175?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:59","pubTimestamp":1788350375,"startTime":"0","endTime":"0","summary":"The latest update is out from uniQure ( ($QURE) ). On September 2, 2026, uniQure submitted a Biologics License Application to the U.S. Food and Dru...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/uniqure-seeks-accelerated-approval-for-huntingtons-gene-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/uniqure-seeks-accelerated-approval-for-huntingtons-gene-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","CNCR","TBXU","FBT","LFSC","BK4585","IBB","GNOM","SYNB","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664864142","title":"Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874","url":"https://stock-news.laohu8.com/highlight/detail?id=2664864142","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664864142?lang=en_us&edition=fundamental","pubTime":"2026-09-02 07:09","pubTimestamp":1788304180,"startTime":"0","endTime":"0","summary":"Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson disposes of 9,000 shares for $422,874Craig C. Hopkinson, EVP R&D, Chief Medical Officer, sold 9,000 ordinary shares on Sep. 1 at USD 46.99.He","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDLgbNz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","PSIL","FBT","BK4139","IBRN","PSCH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664869470","title":"Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869470","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869470?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:05","pubTimestamp":1788293100,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it will participate in a fireside chatat the Morga","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354590/0/en/veracyte-to-participate-in-the-morgan-stanley-24th-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","MS","LU0128526141.USD","BK4581","XLV","BK4139","FBT","HCSG","BK4585","LABU","BK4137","VCYT","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664856297","title":"Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856297","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664856297?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"BRIDGEWATER N.J., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Alan Bash, interim Chief Executi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354079/0/en/legend-biotech-to-participate-in-the-morgan-stanley-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","FBT","HCSG","BK4137","BK4585","GNOM","IBBQ","LU0128526141.USD","XLV","MEMS","LABU","LU0029874061.USD","IBB","TBXU","CNCR","LFSC","BK4505","SYNB","BK4139","CANC","BK4588","MEDI","BK4581","LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985383","title":"Novartis halts autoimmune CAR-T trials following three deaths, Reuters says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985383","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664985383?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258648,"startTime":"0","endTime":"0","summary":"Novartis (NVS) has paused eight clinical trials of rap-cel, an experimental cell therapy targeting autoimmune and neurological disorders, after thr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","LU0320765489.SGD","CNCR","LFSC","IE00BJJMRZ35.SGD","IBBQ","PPH","BK4532","LU0070302665.USD","LU0211331839.USD","BK4588","SYNB","GDOC","IE00B2B36J28.USD","BMED","FBT","IE0009355771.USD","MEDX","NVS","IE00B4R5TH58.HKD","BK4007","IDNA","GNOM","IE00BFTCPJ56.SGD","BK4578","TBXU","LU0208291251.USD","HYLG","IE00BJT1NW94.SGD","BK4585","IE0002141913.USD","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000711","title":"Circio boosts circVec gene therapy data and secures funding runway to 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000711","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000711?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:03","pubTimestamp":1788203022,"startTime":"0","endTime":"0","summary":"The latest update is out from Targovax ASA ( ($GB:0RIS) ). Circio Holding ASA reported that new preclinical data show its circVec circular RNA tech...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","SYNB","IBBQ","FBT","GNOM","BK4139","RNA","BK4588","TBXU","LFSC","IBB","CNCR","BK4585","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663011648","title":"Corcept Therapeutics Insider Makes Major Multimillion-Dollar Stock Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2663011648","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663011648?lang=en_us&edition=fundamental","pubTime":"2026-08-29 10:06","pubTimestamp":1787969183,"startTime":"0","endTime":"0","summary":"New insider activity at Corcept Therapeutics ( ($CORT) ) has taken place on August 28, 2026. Director Park Kimberly has recently cashed out a signi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/corcept-therapeutics-insider-makes-major-multimillion-dollar-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/corcept-therapeutics-insider-makes-major-multimillion-dollar-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","LU1559883803.SGD","BK4007","FBT","CORT","BK4532","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662009682","title":"Labcorp to Present at Morgan Stanley Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662009682","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662009682?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:36","pubTimestamp":1787924191,"startTime":"0","endTime":"0","summary":"Labcorp Holdings ( ($LH) ) has issued an announcement. Labcorp Holdings Inc., a global leader in diagnostics and drug development laboratory servic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/labcorp-to-present-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/labcorp-to-present-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LFSC","BK4585","LABU","BMED","LU0029874061.USD","FBT","BK4588","HCSG","LU0128526141.USD","BK4137","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033320","title":"Corcept Endocrinology President Sean Maduck Disposes of 30,955 Corcept Shares Worth $3.88 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033320","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662033320?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:31","pubTimestamp":1787862696,"startTime":"0","endTime":"0","summary":"Corcept Endocrinology President Sean Maduck disposes of 30,955 Corcept shares worth $3.88 millionCorcept Therapeutics President, Corcept Endocrinology Sean Maduck exercised stock options for 30,955 co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDLbYdy60:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corcept Endocrinology President Sean Maduck Disposes of 30,955 Corcept Shares Worth $3.88 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0566484027.USD","CORT","PSCH","LU1559883803.SGD","BK4007","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703720","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: NeoGenomics (NEO) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703720","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703720?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:10","pubTimestamp":1787825408,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on NeoGenomics (NEO) and Medtronic (MDT). NeoGenomics...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-neogenomics-neo-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-neogenomics-neo-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1506573853.SGD","LU0432979614.USD","LU1989764748.USD","LU1244550494.USD","LU0072461881.USD","LU1571399168.USD","LU1116320737.USD","IE000M9KFDE8.USD","IE00BFXG1179.USD","LU2028103732.USD","LU1244550577.SGD","LABU","IE00BGHQF631.EUR","IE00BVYPNV92.GBP","IE00BQXX3F31.USD","LU0496365809.HKD","LU2089984988.USD","BK4137","NEO","IE00B3PB1722.GBP","LU1116320901.HKD","LU0208291251.USD","LU0211331839.USD","IE00BVYPNW00.USD","IE00B42XCP33.USD","LU0106261372.USD","LU0265550359.USD","BK4585","LU1983299246.USD","XBI","BK4196","LU2023251221.USD","LU1291159041.SGD","BK4566","MDT","LU0162691827.USD","HCSG","LU0158827781.USD","BK4581","FBT","LU0128526141.USD","LU1989764664.SGD","BK4588","LU0012050646.USD","LU0029874061.USD","LU1989771016.USD","XLV","LU0211326839.USD","LU2089283258.USD","LU0006306889.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662744692","title":"NeoGenomics RaDaR ST Gains Expanded Medicare Coverage for Immunotherapy Response Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2662744692","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662744692?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:19","pubTimestamp":1787775586,"startTime":"0","endTime":"0","summary":"NeoGenomics RaDaR ST gains expanded Medicare coverage for immunotherapy response monitoringNeoGenomics secured expanded Medicare coverage from CMS MolDX for its RaDaR ST MRD assay to monitor immunothe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL3k3Zl5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NEO","LU0106261612.USD","FBT","LU0012050646.USD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}